Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Virology

• Publication date

  2017-10-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.01469-17PMID 28978707PMCID PMC5709580
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Zika virus: An emerging flavivirus

  2017cited by this paper
• Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cells

  2017cited by this paper
• CD4+ and CD8+ T‐cell immunity to Dengue – lessons for the study of Zika virus

  2017cited by this paper
• Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection

  2017cited by this paper
• Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus

  2017cited by this paper
• Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection

  2016cited by this paper
• Protective Role of Cross-Reactive CD8 T Cells Against Dengue Virus Infection

  2016cited by this paper
• Zika Virus in the Americas — Yet Another Arbovirus Threat

  2016cited by this paper
• Structural basis of potent Zika–dengue virus antibody cross-neutralization

  2016cited by this paper
• Human CD4+ T Cell Responses to an Attenuated Tetravalent Dengue Vaccine Parallel Those Induced by Natural Infection in Magnitude, HLA Restriction, and Antigen Specificity

  2016cited by this paper
• Zika Virus.

  2016cited by this paper
• Immunodominant Dengue Virus-Specific CD8+ T Cell Responses Are Associated with a Memory PD-1+ Phenotype

  2016cited by this paper
• Identifying Candidate Targets of Immune Responses in Zika Virus Based on Homology to Epitopes in Other Flavivirus Species

  2016cited by this paper
• Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India

  2016cited by this paper
• Zika virus and microcephaly

  2016cited by this paper
• HLA-DRB1 Alleles Are Associated With Different Magnitudes of Dengue Virus-Specific CD4+ T-Cell Responses.

  2016cited by this paper
• Single-Reaction Multiplex Reverse Transcription PCR for Detection of Zika, Chikungunya, and Dengue Viruses

  2016cited by this paper
• Zika Virus and Microcephaly.

  2016cited by this paper
• Structural basis of potent Zika–dengue virus antibody cross-neutralization

  2016cited by this paper
• Clinical evaluation of a single-reaction real-time RT-PCR for pan-dengue and chikungunya virus detection.

  2016cited by this paper
• Zika Virus

  2016cited by this paper
• Diagnostics for Zika virus on the horizon

  2016cited by this paper
• Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus

  2016cited by this paper
• Zika Virus: Immunity and Vaccine Development

  2016cited by this paper
• Human T cell responses to Japanese encephalitis virus in health and disease

  2016cited by this paper
• TepiTool: A Pipeline for Computational Prediction of T Cell Epitope Candidates

  2016cited by this paper
• The Emergence of Zika Virus as a Global Health Security Threat: A Review and a Consensus Statement of the INDUSEM Joint working Group (JWG)

  2016cited by this paper
• Zika Virus in the Americas--Yet Another Arbovirus Threat.

  2016cited by this paper
• Zika virus and microcephaly: why is this situation a PHEIC?

  2016cited by this paper
• Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus

  2016cited by this paper
• Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus

  2016cited by this paper
• Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults.

  2015cited by this paper
• Human CD8+ T-Cell Responses Against the 4 Dengue Virus Serotypes Are Associated With Distinct Patterns of Protein Targets.

  2015cited by this paper
• Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity

  2015cited by this paper
• The Human CD8+ T Cell Responses Induced by a Live Attenuated Tetravalent Dengue Vaccine Are Directed against Highly Conserved Epitopes

  2014cited by this paper
• The two faces of heterologous immunity: protection or immunopathology

  2014cited by this paper
• Immunodominance Changes as a Function of the Infecting Dengue Virus Serotype and Primary versus Secondary Infection

  2014influential reference
• T-Cell Immunity to Infection with Dengue Virus in Humans

  2014cited by this paper
• Single-Reaction, Multiplex, Real-Time RT-PCR for the Detection, Quantitation, and Serotyping of Dengue Viruses

  2013cited by this paper
• A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial.

  2013cited by this paper
• Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells

  2013cited by this paper
• Neuroinvasive flavivirus infections

  2012cited by this paper
• Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms

  2011cited by this paper
• Insights into human CD8+ T‐cell memory using the yellow fever and smallpox vaccines

  2011cited by this paper
• Meningitis determined by oligosymptomatic dengue virus type 3 infection: report of a case.

  2010cited by this paper
• This information is current as T Cell Responses + Lack of Original Antigenic Sin in Recall CD 8

  2010cited by this paper
• A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults.

  2010cited by this paper
• Heterologous immunity between viruses

  2010cited by this paper
• The Nicaraguan Pediatric Dengue Cohort Study: Study Design, Methods, Use of Information Technology, and Extension to Other Infectious Diseases

  2009cited by this paper
• The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response1

  2009cited by this paper
• Severe Dengue Epidemics in Sri Lanka, 2003–2006

  2009cited by this paper
• Comprehensive analysis of west nile virus-specific T cell responses in humans.

  2008cited by this paper
• Involvement of the central nervous system in patients with dengue virus infection.

  2008cited by this paper
• Genetic and Serologic Properties of Zika Virus Associated with an Epidemic, Yap State, Micronesia, 2007

  2008cited by this paper
• Comparison of Plaque- and Flow Cytometry-Based Methods for Measuring Dengue Virus Neutralization

  2007cited by this paper
• High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua

  2006cited by this paper
• A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus

  2006cited by this paper
• Serological diagnosis of dengue by an ELISA inhibition method (EIM).

  1990cited by this paper

• Multi-antigen DNA vaccine targeting non-structural proteins confers robust T Cell-mediated protection against Zika virus

  2026cites this paper
• Opportunities and Challenges of mRNA and VLP Technologies for Pan-Flavivirus Vaccine Development: Focus on Conserved Quaternary Epitope Conformations

  2026cites this paper
• From Antibodies to Immunity: Assessing Correlates of Flavivirus Protection and Cross-Reactivity

  2025cites this paper
• Zika virus-induced fetal demise is triggered by strain- and dose-specific RLR-driven activation of the interferon response in the decidua, placenta, and fetus in Ifnar1−/− mice

  2025cites this paper
• Lentiviral vector-based T-cell vaccines against Zika and yellow fever viruses.

  2025cites this paper
• Human T Cell Responses to Flavivirus Vaccines

  2025cites this paper
• Time Series Analysis of Dengue, Zika, and Chikungunya in Ecuador: Emergence Patterns, Epidemiological Interactions, and Climate-Driven Dynamics (1988–2024)

  2025cites this paper
• Pre-existing YFV-17D immunity mediates T cell cross-protection against dengue virus serotype 2 infection in mice

  2025cites this paper
• T-Cell-Based Universal Dengue Vaccine Design for Robust Protective Response

  2025cites this paper
• Enhanced durability of a Zika virus self-amplifying RNA vaccine through combinatorial OX40 and 4-1BB agonism

  2025cites this paper
• Zika virus-induced fetal demise is driven by strain- and dose-specific RLR-driven activation of the interferon response in the decidua, placenta, and fetus in Ifnar1−/− mice

  2025cites this paper
• A bivalent self-amplifying RNA vaccine against yellow fever and Zika viruses

  2025cites this paper
• A Roadmap Towards the Identification and Validation of Conserved T Cell Epitope Regions in Viral Pathogen Families with Pandemic Potential.

  2025cites this paper
• Proceedings of the second annual dengue endgame summit: A call to action

  2025cites this paper
• Heterologous prime–boost Zika virus vaccination induces comprehensive humoral and cellular immunity in mouse models

  2025cites this paper
• The Emerging Role of Circulating T Follicular Helper Cells in Dengue Virus Immunity: Balancing Protection and Pathogenesis

  2025influential citation
• Dengue Dilemma: Navigating Cross-Reactivity and Immune Challenges.

  2025cites this paper
• Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice

  2024cites this paper
• Animal Models, Therapeutics, and Vaccine Approaches to Emerging and Re-Emerging Flaviviruses

  2024cites this paper
• Zika virus T-cell based 704/DNA vaccine promotes protection from Zika virus infection in the absence of neutralizing antibodies

  2024cites this paper
• The Flavivirus Non-Structural Protein 5 (NS5): Structure, Functions, and Targeting for Development of Vaccines and Therapeutics

  2024cites this paper
• Advancing arbovirus diagnosis in Brazil: strengthening diagnostic strategies and public health data collection

  2024cites this paper
• Continuing development of vaccines and monoclonal antibodies against Zika virus

  2024cites this paper
• Comprehensive analysis of early T cell responses to acute Zika Virus infection during the first epidemic in Bahia, Brazil

  2024cites this paper
• Regional Variation of the CD4 and CD8 T Cell Epitopes Conserved in Circulating Dengue Viruses and Shared with Potential Vaccine Candidates

  2024cites this paper
• An Update on Zika Virus Vaccine Development and New Research Approaches

  2024cites this paper
• Durable cellular immune response against inactivated ZIKV and envelope proteins in ZIKV-infected women during pregnancy

  2024cites this paper
• Zika virus precursor membrane peptides induce immune response in peripheral blood mononuclear cells.

  2024cites this paper
• The MegaPool Approach to Characterize Adaptive CD4+ and CD8+ T Cell Responses

  2023cites this paper
• Effects of boosting and waning in highly exposed populations on dengue epidemic dynamics

  2023cites this paper
• Antibody cross-reactivity and evidence of susceptibility to emerging Flaviviruses in the dengue-endemic Brazilian Amazon.

  2023cites this paper
• In silico codon optimization of the variant antigen-encoding genes of diverse strains of Zika Virus

  2023cites this paper
• Recombinant protein based on domain III and capsid regions of zika virus induces humoral and cellular immune response in immunocompetent BALB/c mice.

  2023cites this paper
• Immunoinformatics-Based Identification of the Conserved Immunogenic Peptides Targeting of Zika Virus Precursor Membrane Protein

  2023cites this paper
• Shifting patterns of dengue three years after Zika virus emergence in Brazil

  2023cites this paper
• Superior efficacy of a skin-applied microprojection device for delivering a novel Zika DNA vaccine

  2023cites this paper
• Evaluation of the immunogenicity and efficacy of an rVSV vaccine against Zika virus infection in macaca nemestrina

  2023cites this paper
• ZIKV-envelope proteins induce specific humoral and cellular immunity in distinct mice strains

  2022cites this paper
• Zika virus NS2B-NS3 protease: Quantum chemical properties insights for designing inhibitory peptides.

  2022cites this paper
• Host immune response against DENV and ZIKV infections

  2022cites this paper
• Infection order outweighs the role of CD4+ T cells in tertiary flavivirus exposure

  2022cites this paper
• Mucosal Vaccination: A Promising Alternative Against Flaviviruses

  2022cites this paper
• The Role of Antibodies in the Treatment of SARS-CoV-2 Virus Infection, and Evaluating Their Contribution to Antibody-Dependent Enhancement of Infection

  2022cites this paper
• Inducing broad-based immunity against viruses with pandemic potential.

  2022cites this paper
• Antibody cross-reactivity and evidence of susceptibility to emerging Flaviviruses in the dengue-endemic Brazilian Amazon

  2022cites this paper
• Peculiarities of Zika Immunity and Vaccine Development: Lessons from Dengue and the Contribution from Controlled Human Infection Model

  2022cites this paper
• A cytotoxic-skewed immune set point predicts low neutralizing antibody levels after Zika virus infection

  2022cites this paper
• Current Understanding of the Role of T Cells in Chikungunya, Dengue and Zika Infections

  2022cites this paper
• Involvement of Th1Th17 Cell Subpopulations in the Immune Responses of Mothers Who Gave Birth to Children with Congenital Zika Syndrome (CZS)

  2022influential citation
• Infection order outweighs the role of CD4+ T cells in tertiary flavivirus infection

  2022cites this paper
• New insights into the recombinant proteins and monoclonal antibodies employed to immunodiagnosis and control of Zika virus infection: A review.

  2022cites this paper
• The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses

  2022cites this paper
• Immunization with Usutu virus and with a chimeric West Nile virus (WNV) harboring Usutu-E protein protects immunocompetent adult mice against lethal challenges with different WNV lineage 1 and 2 strains.

  2022cites this paper
• Vaccination with a Zika virus envelope domain III protein induces neutralizing antibodies and partial protection against Asian genotype in immunocompetent mice

  2022cites this paper
• Can the triumph of mRNA vaccines against COVID-19 be extended to other viral infections of humans and domesticated animals?

  2022cites this paper
• Effect of prior Zika and dengue virus exposure on the severity of a subsequent dengue infection in adults

  2022cites this paper
• Pathogenesis of Zika Virus Infection

  2022cites this paper
• Reporter Virus Neutralization Test Evaluation for Dengue and Zika Virus Diagnosis in Flavivirus Endemic Area

  2021cites this paper
• Pre-existing T Cell Memory against Zika Virus

  2021cites this paper
• A vaccine inducing solely cytotoxic T lymphocytes fully prevents Zika virus infection and fetal damage

  2021cites this paper
• Gist of Zika Virus pathogenesis.

  2021cites this paper
• Distinct cellular immune signatures in acute Zika virus infection are associated with high or low persisting neutralizing antibody titers

  2021cites this paper
• Zika virus infection during pregnancy protects against secondary infection in the absence of CD8+ cells

  2021cites this paper
• The legacy of ZikaPLAN: a transnational research consortium addressing Zika

  2021cites this paper
• A Novel Orf Virus D1701-VrV-Based Dengue Virus (DENV) Vaccine Candidate Expressing HLA-Specific T Cell Epitopes: A Proof-of-Concept Study

  2021influential citation
• Pathogenesis and virulence of flavivirus infections

  2021cites this paper
• Hide and Seek: The Interplay Between Zika Virus and the Host Immune Response

  2021cites this paper
• Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term

  2021cites this paper
• Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine

  2021cites this paper
• Differential Longevity of Memory CD4 and CD8 T Cells in a Cohort of the Mothers With a History of ZIKV Infection and Their Children

  2021cites this paper
• Evaluation of the Expression of CCR5 and CX3CR1 Receptors and Correlation with the Functionality of T Cells in Women infected with ZIKV during Pregnancy

  2021cites this paper
• Prior Heterologous Flavivirus Exposure Results in Reduced Pathogenesis in a Mouse Model of Zika Virus Infection

  2021cites this paper
• Nation-wide vector surveillance on Zika and Dengue did not indicate transmission of the "American lineage pandemic ZIKA virus" in India.

  2021cites this paper
• Zika Virus Pathogenesis: A Battle for Immune Evasion

  2021influential citation
• Viral-Immune Cell Interactions at the Maternal-Fetal Interface in Human Pregnancy

  2020cites this paper
• Strong CD4 T Cell Responses to Zika Virus Antigens in a Cohort of Dengue Virus Immune Mothers of Congenital Zika Virus Syndrome Infants

  2020influential citation
• Cross-Reactive Immunity Among Flaviviruses

  2020cites this paper
• Crosstalk between RNA Metabolism and Cellular Stress Responses during Zika Virus Replication

  2020cites this paper
• T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species

  2020cites this paper
• Single cell immune profiling of dengue virus patients reveals intact immune responses to Zika virus with enrichment of innate immune signatures

  2020cites this paper
• Defeat Dengue and Zika Viruses With a One-Two Punch of Vaccine and Vector Blockade

  2020cites this paper
• Two Is Better Than One: Evidence for T-Cell Cross-Protection Between Dengue and Zika and Implications on Vaccine Design

  2020cites this paper
• Virus-Induced T Cell-Mediated Heterologous Immunity and Vaccine Development

  2020cites this paper
• Immunogenicity and Efficacy of a Recombinant Human Adenovirus Type 5 Vaccine against Zika Virus

  2020cites this paper
• Update on T cells in the virally infected brain: friends and foes

  2020cites this paper
• Comprehensive Immunoprofiling of Pediatric Zika Reveals Key Role for Monocytes in the Acute Phase and No Effect of Prior Dengue Virus Infection.

  2020cites this paper
• CD4+ T Cells Cross-Reactive with Dengue and Zika Viruses Protect against Zika Virus Infection

  2020cites this paper
• The continued threat of emerging flaviviruses

  2020cites this paper
• Zika virus infection during pregnancy protects against secondary infection in the absence of CD8+ cells

  2020cites this paper
• Identification of Dengue Virus Serotype 3 Specific Antigenic Sites Targeted by Neutralizing Human Antibodies.

  2020cites this paper
• Effective control of early Zika virus replication by Dengue immunity is associated to the length of time between the 2 infections but not mediated by antibodies

  2020cites this paper
• The Nuclear Pore Complex: A Target for NS3 Protease of Dengue and Zika Viruses

  2020cites this paper
• Immunological Memory to Zika Virus in a University Community in Colombia, South America.

  2020cites this paper
• Current Status of Zika Virus Vaccines: Successes and Challenges

  2020cites this paper
• Multifunctional T cell response in convalescent patients two years after ZIKV infection

  2020cites this paper
• Immune outcomes of Zika virus infection in nonhuman primates

  2020cites this paper
• Proteome-Wide Zika Virus CD4 T Cell Epitope and HLA Restriction Determination

  2020cites this paper
• Protection against dengue virus requires a sustained balance of antibody and T cell responses.

  2020cites this paper
• Zika virus infection enhances future risk of severe dengue disease

  2020cites this paper
• Protective and enhancing interactions among dengue viruses 1-4 and Zika virus.

  2020cites this paper